about
Luzp4 defines a new mRNA export pathway in cancer cellsTrial watch: Dendritic cell-based anticancer therapyHypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.The Stress-response protein prostate-associated gene 4, interacts with c-Jun and potentiates its transactivation.Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers.Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.Overexpressed oncogenic tumor-self antigensEffect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cellsNovel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.Specific autoantigens identified by sera obtained from mice that are immunized with testicular germ cells alone.Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.Inducible expression of cancer-testis antigens in human prostate cancer.Decitabine: a promising epi-immunotherapeutic agent in solid tumors.The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.Cancer/testis antigen PAGE4, a regulator of c-Jun transactivation, is phosphorylated by homeodomain-interacting protein kinase 1, a component of the stress-response pathway.The cancer-retina antigen recoverin as a potential biomarker for renal tumors.Nanowire analysis of cancer-testis antigens as biomarkers of aggressive prostate cancer.Genomic screening of testicular germ cell tumors from monozygotic twinsProstate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target.
P2860
Q24318387-69CF424E-C948-4DF6-8473-78827C3FB23BQ27024047-29C98D34-0566-4258-A6BA-5C0A168F0F99Q33572253-38C74469-A9B5-468D-9DBE-8DD8CF487530Q33862856-519B2935-C15A-49DD-9D17-19A2BB1F1E10Q34029148-3CC88FE4-5B4E-42C0-ADC6-FE039D573A6BQ34256170-D37CEE13-8740-442B-A828-7FCA8F3C80B4Q35776228-4399AF06-51E0-4231-9551-B0A7221400C2Q35886756-CFCF6665-A80C-42FB-B33C-118AD164F9E1Q36327590-9450779C-6B2E-430E-BD8F-4F515FE162EBQ37046496-C7D8C38D-4118-499A-8E16-1C2E0EFA5F3AQ37345382-D514DAAA-2F4F-4731-A33E-A69C8A0F40DBQ37622580-C5408D38-52F3-4CA2-A6FA-F915AACA9A08Q37686238-049C02BE-D4B9-4562-9248-D7FD24E0DF5DQ38314204-1F41C22D-DCCB-4558-931E-1FE8D693456EQ38962561-F25F5E77-2DE9-4E53-B131-118820C0A299Q39021870-AADF0EE8-8F2F-4994-8E8A-C23B13669F72Q40058624-CD3B5FFA-B42D-4DA7-89CD-C77C57B1C6D7Q41496498-397FE494-1A7A-42AC-8D0C-E392C1F54F6BQ41952598-EBF34BC8-235F-4490-BD8E-02357893BA9BQ55515702-ED2E3A69-E041-40CB-A5CC-96C2F4A44778
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cancer/testis antigens and urological malignancies
@ast
Cancer/testis antigens and urological malignancies
@en
type
label
Cancer/testis antigens and urological malignancies
@ast
Cancer/testis antigens and urological malignancies
@en
prefLabel
Cancer/testis antigens and urological malignancies
@ast
Cancer/testis antigens and urological malignancies
@en
P2093
P2860
P356
P1476
Cancer/testis antigens and urological malignancies
@en
P2093
Krithika Rajagopalan
Prakash Kulkarni
Robert H Getzenberg
Robert Kim
Steven M Mooney
Takumi Shiraishi
P2860
P2888
P304
P356
10.1038/NRUROL.2012.117
P407
P577
2012-06-19T00:00:00Z
P5875
P6179
1021508220